ArticleFrontiers in oncology2025
Temporal trends and future projections of six major cancers among women of childbearing age in northeast Asia: analysis of data from the global burden of disease study 2021.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Temporal Trends and Model-Based Projections of Female-Specific Cancer Burden Among East Asian Women Aged 55 Years and Older: A GBD 2023 Analysis.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cancer among women of childbearing age (WCBA) imposes major health and socioeconomic burdens, yet integrated assessments of temporal trends and future projections in Northeast Asia (NEA) are limited. Methods: Using Global Burden of Disease 2021 estimates, we quantified incidence, mortality, and disability-adjusted life years (DALYs) for breast, cervical, uterine, ovarian, colorectal (CRC), and tracheal, bronchus, and lung (TBL) cancers among women of childbearing age (WCBA; 15-49 years) in six Northeast Asia countries from 1990-2021. We calculated age-standardized incidence, mortality and DALY rates, temporal odds ratios for the proportion of WCBA among all female cases, estimated annual percentage changes (EAPCs), and mortality-to-incidence ratios (MIRs), referencing a 46.6% threshold. Age-standardized incidence and mortality rates to 2050 were projected using Bayesian age-period-cohort models fitted with integrated nested Laplace approximation. Findings: Between 1990 and 2021, the proportion of cancer incidence, deaths, and DALYs among WCBA relative to all females declined across all cancer types. The steepest proportional declines were for TBL incidence ( Interpretation: Although mortality and DALYs among WCBA in NEA have improved, rising breast and uterine cancer incidence, persistently high lung cancer MIRs remain major concerns. Strengthened tobacco control and air-quality policies, expanded HPV vaccination and cervical screening, promotion of healthy lifestyles, and equitable access to early diagnosis and treatment are essential to reduce cross-country disparities in cancer outcomes among WCBA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.